HB 309

  • Delaware House Bill
  • 151st General Assembly (2021-2022)
  • Introduced in House Mar 17, 2022
  • Passed House Mar 17, 2022
  • Passed Senate Jun 30, 2022
  • Signed by Governor Aug 04, 2022

An Act To Amend Title 16 Of The Delaware Code Relating To The Provision Of Information About Lyme Disease.

Abstract

This Act, modeled on similar laws in Virginia and Maryland, requires a health-care provider to provide notice to a patient at the time blood is drawn to perform a laboratory test for Lyme disease that explains the limitations of the test and instructs the patient to see their health-care provider if the patient continues to experience unexplained symptoms. This Act was previously passed by the 150th General Assembly in Senate Bill 15, and is the same except for the removal of the sunset provision.

Bill Sponsors (26)

Votes


Jun 30, 2022

Mar 17, 2022

Actions


Aug 04, 2022

Office of the Governor

Signed by Governor

Jun 30, 2022

Senate

Passed By Senate. Votes: 21 YES

Apr 06, 2022

Senate

Reported Out of Committee (Health & Social Services) in Senate with 5 Favorable, 1 On Its Merits

  • Committee-Passage
  • Committee-Passage-Favorable
Health & Social Services

Mar 17, 2022

Senate

Assigned to Health & Social Services Committee in Senate

  • Introduction
  • Referral-Committee
Health & Social Services

House

Passed By House. Votes: 41 YES

Mar 16, 2022

House

Reported Out of Committee (Health & Human Development) in House with 9 Favorable, 3 On Its Merits

  • Committee-Passage
  • Committee-Passage-Favorable
Health & Human Development

Mar 03, 2022

House

Introduced and Assigned to Health & Human Development Committee in House

  • Introduction
  • Referral-Committee
Health & Human Development

Bill Text

Bill Text Versions Format
Bill Text PDF HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Delaware General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.